Horizon Pharma Accounts Payable:
5.986M for Dec. 31, 2012Horizon Pharma Historical Accounts Payable Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | 5.986M |
| Sept. 30, 2012 | 6.854M |
| June 30, 2012 | 7.89M |
| March 31, 2012 | 8.752M |
| Dec. 31, 2011 | 8.17M |
| Sept. 30, 2011 | 3.723M |
| June 30, 2011 | 5.043M |
| March 31, 2011 | 3.865M |
| Dec. 31, 2010 | 2.514M |
| Sept. 30, 2010 | 4.404M |
| June 30, 2010 | 3.847M |
| March 31, 2010 | 2.259M |
| Dec. 31, 2009 | 1.761M |
About Accounts Payable
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
For example, accounts payable increases when a company purchases inventory "on account." When the money is repaid, accounts payable decreases.
YCharts takes accounts payable numbers directly from balance sheet line items.
Learn More
HZNP Accounts Payable Benchmarks
| Companies | |
|---|---|
| Rigel Pharmaceuticals | 1.697M |
| Sagent Pharmaceuticals | 22.40M |
| Valeant Pharmaceuticals International | 183.02M |
HZNP Accounts Payable Rankings
| Overall |
68th percentile 2507 of 8002 |
| Sector |
67th percentile 210 of 650 in Healthcare |
| Industry |
72nd percentile 18 of 65 in Drug Manufacturers - Specialty & Generic |
HZNP Accounts Payable Range, Past 5 Years
| Minimum | 1.761M | Dec 2009 |
| Maximum | 8.752M | Mar 2012 |
| Average | 5.005M |
